期刊
CLINICAL BIOCHEMISTRY
卷 43, 期 1-2, 页码 168-177出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.clinbiochem.2009.10.006
关键词
CF; Asthma; COPD; Proteomics; SELDI-TOF-MS; Biomarkers signatures
资金
- FCT/FEDER [POCTI/MGI/40878/2001, POCI/SAU-MMO/56163/2004]
- FCT/Poly-Annual Funding Program
- FEDER/Saude-XXI-Program (Portugal)
- FCT-PhD fellowship [SFRH/BD/17744/2004]
- Medical Research Council [G9900991B] Funding Source: researchfish
Objectives: The aim of this work was to establish protein profiles in serum and nasal epithelial cells of cystic fibrosis individuals in comparison with controls, asthma and chronic obstructive pulmonary disease patients for specific biomarker signatures identification. Design and methods: Protein extracts were analyzed by Surface Enhanced Laser Desorption/Ionization Time-Of-Flight Mass-Spectrometry (SELDI-TOF-MS). Results: The mass spectra revealed a set of peaks with differential expression in serum and nasal cells among the different groups studied, resulting into peak signatures representative/specific of each pathology. Logistic regressions were applied to those peaks; sensitivity, specificity, Youden's indexes and area under the curve (AUC) of the respective receiver operating characteristic (ROC) curves were compared. Discussion: Multivariate analysis demonstrated that combination of peaks has a better predictive value than the individual ones. These protein signatures may serve as diagnostic/prognostic markers for the studied diseases with common clinical features, or as follow-up assessment markers of therapeutic interventions. (c) 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All fights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据